Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-01-01 @ 4:54 AM
Study NCT ID:
NCT02120469
Status:
COMPLETED
Last Update Posted:
2022-07-05
First Post:
2014-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-18
First Submit QC Date:
None
Study First Post Date:
2014-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-10-19
Results First Submit QC Date:
None
Results First Post Date:
2022-04-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-06
Last Update Post Date:
2022-07-05
Last Update Post Date Type:
ACTUAL